Page 3 - Dabur

SPAC mergers are here to stay, says Gaurav Burman, scion of Dabur family

There are 578 active special purpose acquisition companies, with a combined capital of about $172 billion

Dabur India's profit after tax jumps 28.4%, beats pre-Covid levels

The firm reported a 28.4 per cent jump in its profit after tax (PAT) on a year-on-year basis

Dabur posts 28% rise in Q1 profit for Rs 438.30 cr on healthy sales growth

The company had posted a net profit of Rs 341.30 crore in the April-June quarter a year ago, Dabur India said in a BSE filing.

Stocks to watch: Airtel, RBL Bank, Tata Motors, VA Tech Wabag, Dabur, NCC

Tata Sons arm Panatone Finvest picked up an 8 per cent stake in domestic telecom equipment maker Tejas Networks for over Rs 193 crore through an open market transaction

Dabur's non-executive chairman Amit Burman hospitalised in London

Homegrown FMCG major Dabur India on Monday said its Non-Executive Chairman Amit Burman has undergone a successful surgery in London for treating a case of aneurysm. Burman (52) is recuperating, Dabur India said in a regulatory filing, adding the surgery was successful and his health is improving. "Doctors are constantly monitoring his condition and have advised him to take rest," it added. Aneurysm is a bulge in a blood vessel caused by a weakness in the wall of the blood vessel. Burman, who started his career at Dabur's Industrial Engineering Department taking charge for induction of machinery, method improvements, manpower reduction and improving product packaging, is responsible for the company's foray into processed foods business with the setting up of Dabur Foods Ltd. He became the CEO of Dabur Foods in 1999 and led the company's foray into processed foods business with a range of ethnic cooking pastes and chutneys and packaged fruit juices. In July 2007, he stepped down as

Not very concerned about third wave impact on biz: Dabur India CEO

Share of our healthcare portfolio went up to 45 per cent from 30 per cent and essentials like oral care did well, while share of skin-care, hair oils, and foods shrank, says CEO

Dabur to spend Rs 550 cr on new MP plant in largest location-wise exposure

The firm has secured 51 acres of land and begun construction work for the initial phase, which is to be completed within the current financial year

Colgate-Palmolive shifts focus as Dabur, Patanjali ride herbal wave

While Colgate has the Vedshakti brand in the naturals segment, experts say the product has not helped stem market share loss for the oral care major

Dabur's consolidated net profit rises 34% to Rs 377 crore in March quarter

Homegrown FMCG major Dabur India Ltd on Friday reported an increase of 33.98 per cent in consolidated net profit at Rs 377.29 crore for the fourth quarter ended March 2021

Dabur m-cap tops Rs 1 trillion, shares up 2.2% to lifetime high of Rs 573

Stock has gained 9% in a month even as Sensex shed 3% during this period. Currently, 41 listed companies have market cap exceeding Rs 1 trillion

Nestle India digs deeper in the rural market, aims to grow business

The company's new-found enthusiasm for the hinterlands is founded on its appetite for growth

Losers and gainers in Indian industry as fuel prices climb to record high

Expensive retail fuel can trigger inflation, hurting a fragile economic recovery. Devangshu Datta explains who loses - and gains somewhat - when prices rise

HUL, ITC, Tata Consumer: FMCG sector on verge of breakout; stay invested

ITC stock is struggling to conquer the resistance of Rs 215 to Rs 220 levels. The downside support stays at Rs 200

Bitter Marico-Dabur war over honey adulteration offers food for thought

When the issue concerns people's health, it's more than just a clash of brands, says experts

Dabur, Marico hit out against each other at ASCI over claims on honey

Two leading homegrown rival FMCG brands Dabur and Marico are in an open spat with each other over claims regarding their honey brands and have taken the matter to advertising regulator ASCI. Dabur on Sunday said it is filing a complaint against rival Marico before the Advertising Standards Council of India (ASCI) for claiming its Saffola Honey sample being passed through the NMR test. The Noida-based company claimed Marico's Saffola honey has failed the NMR (Nuclear Magnetic Resonance) test and is misleading the consumers. "Dabur is filing a complaint in ASCI against Marico as their Saffola Honey sample from the market has failed the NMR test. Test reports clearly indicate the presence of sugar syrup in Saffola honey. Their claim on NMR test is misleading the consumers," Dabur claimed in a statement. However, Dabur's claim was refuted by Marico contending that Saffola Honey is also compliant with each of the quality parameters mandated by FSSAI". Earlier, Marico had filed a compla

Leading honey brands fail adulteration test by foreign lab, says CSE

Only Marico's Saffola Honey clears all tests; Dabur, Emami, Patanjali say their products safe

From veggie tacos to healthcare: Dabur's Gaurav Burman opens up on his bets

Burman, 48, runs his family office, which oversees about $1.5 billion in assets

Small firms losing market to big FMCG brands as buyers go for trusted names

Normalcy in operations, push into rural areas aid growth

Lessons from Covid-19: Happiness in simple things, says Dabur India chief

Things have now settled down to a routine

Dabur's aggressive focus on healthcare products is paying off

Segment supported performance in Q1, which saw revenue decline by 12.9% and PBT by 8.5%